Screening and Identifying Cisplatin-Related Gene Mutations in Lung Squamous Cell Carcinoma

INTRODUCTION: Platinum-based chemotherapy is the cornerstone of treatment for patients with LUSC, but cisplatin resistance greatly restricts its clinical application. Therefore, it is particularly important to screen the predominant LUSC population using biomarkers. METHODS: Data for 15 LUSC cell li...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaohua, Wang, Yuntao, Hu, Sheng, Bai, Yifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755377/
https://www.ncbi.nlm.nih.gov/pubmed/33376383
http://dx.doi.org/10.2147/PGPM.S264545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755377/
https://www.ncbi.nlm.nih.gov/pubmed/33376383
http://dx.doi.org/10.2147/PGPM.S264545

Ejemplares similares